Dow Up 0.12% Nasdaq Up 1.35%

Novo Nordisk A/S (NVO)

-NYSE
44.95 0.63(1.42%) Oct 20, 4:02PM EDT
Prev Close:44.32
Open:44.25
Bid:44.94 x 8900
Ask:45.08 x 8900
1y Target Est:49.37
Beta:0.8
Next Earnings Date:N/A
Day's Range:44.07 - 45.04
52wk Range:33.04 - 49.11
Volume:1,155,218
Avg Vol (3m):1,069,570
Market Cap:118.17B
P/E (ttm):26.82
EPS (ttm):1.68
Div & Yield:0.61 (1.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 1.42%118.17B
LLY67.62B
PFE177.10B
SNY135.88B

Key Statistics

Forward P/E (1 yr):22.59
P/S (ttm):8.05
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.77
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback